<DOC>
	<DOCNO>NCT00969618</DOCNO>
	<brief_summary>The purpose study ass long-term safety tolerability adult patient complete previous atomoxetine study .</brief_summary>
	<brief_title>A Long Term Follow-Up Study Asian Adult Patients With Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients complete B4ZJELYEE study ( NCT00962104 ) sign Informed Consent Document ( ICD ) . Patients must judge investigator reliable keep appointment clinic visit test , include venipuncture examination , require protocol . Patients must possess educational level degree understanding language country enable communicate suitably investigator study coordinator . Patients meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision criterion current anxiety disorder also patient require antianxiety drug therapy within previous study except take benzodiazepine analog anxiety . The dosage diazepam equivalents 5 milligrams/day ( mg/day ) . Patients , opinion investigator , serious suicidal risk serious risk harm others , whose score Item 11 Hamilton Depression Rating Scale17 item equal 2 randomization screening . Patients significant medical condition likely become unstable trial would likely destabilize treatment atomoxetine require treatment exclude medication . Patients history allergy atomoxetine , severe allergy 1 class medication , multiple adverse drug reaction . Patients receive treatment within past 30 day drug receive regulatory approval indication time inform consent document obtain .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ADHD</keyword>
</DOC>